U.S. Federal and State Cases, Codes, and Articles
Select a tab to search United States Cases, Codes, or Articles
U.S. Federal and State Cases, Codes, and Articles
Select a tab to search United States Cases, Codes, or Articles
Search for cases
Indicates required field
Search by keyword or citation
Indicates required field
Search blogs, article pages, and cases and codes
Indicates required field
Current as of February 19, 2021 | Updated by FindLaw Staff
a. (1) The Commissioner of Health shall report to the Governor and, pursuant to section 2 of P.L.1991, 164 (C.52:14-19.1), the Legislature, no later than one year after the effective date of P.L.2006, c. 99 (C.26:5C-25 et seq.) and biennially thereafter, on the status of sterile syringe access programs established pursuant to sections 3 and 4 of P.L.2006, c. 99 (C.26:5C-27 and C.26:5C-28), as amended by P.L.2016, c. 36, and shall include in that report the data provided to the commissioner by each sterile syringe access program pursuant to paragraph (11) of subsection b. of section 4 of P.L.2006, c. 99 (C.26:5C-28), as amended by P.L.2016, c. 36.
(2) For the purpose of each biennial report pursuant to paragraph (1) of this subsection, the commissioner shall:
(a) consult with local law enforcement authorities regarding the impact of the sterile syringe access programs on the rate and volume of crime in the affected municipalities and include that information in the report; and
(b) seek to obtain data from public safety and emergency medical services providers Statewide regarding the incidence and location of needle stick injuries to their personnel and include that information in the report.
b. (Deleted by amendment, P.L.2016, c. 36)
c. The commissioner shall prepare a detailed analysis of the sterile syringe access programs, and report on the results of that analysis to the Governor, the Governor's Advisory Council on HIV/AIDS and Related Blood-Borne Pathogens, and, pursuant to section 2 of P.L.1991, c. 164 (C.52:14-19.1), the Legislature annually. The analysis shall include, but not be limited to:
(1) any increase or decrease in the spread of HIV, hepatitis C and other bloodborne pathogens that may be transmitted by the use of contaminated syringes and needles;
(2) the number of exchanged syringes and needles and an evaluation of the disposal of syringes and needles that are not returned by consumers;
(3) the number of consumers participating in the sterile syringe access programs and an assessment of their reasons for participating in the programs;
(4) the number of consumers in the sterile syringe access programs who participated in substance use disorder treatment programs; and
(5) the number of consumers in the sterile syringe access programs who benefited from counseling and referrals to programs and entities that are relevant to their health, housing, social service, employment and other needs.
d. (Deleted by amendment, P.L.2016, c. 36)
Cite this article: FindLaw.com - New Jersey Statutes Title 26. Health and Vital Statistics 26 § 5C-29 - last updated February 19, 2021 | https://codes.findlaw.com/nj/title-26-health-and-vital-statistics/nj-st-sect-26-5c-29/
FindLaw Codes may not reflect the most recent version of the law in your jurisdiction. Please verify the status of the code you are researching with the state legislature or via Westlaw before relying on it for your legal needs.
A free source of state and federal court opinions, state laws, and the United States Code. For more information about the legal concepts addressed by these cases and statutes, visit FindLaw's Learn About the Law.
Get help with your legal needs
FindLaw’s Learn About the Law features thousands of informational articles to help you understand your options. And if you’re ready to hire an attorney, find one in your area who can help.
Search our directory by legal issue
Enter information in one or both fields (Required)